Join
Live feed
·
NEWSReleasevia Quantisnow
Gilead Sciences Inc. logo

Cantor Fitzgerald Maintains Neutral on Gilead Sciences, Lowers Price Target to $70

ByQuantisnow·Wall Street's wire, on your screen.
GILD· Gilead Sciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GILD (Gilead Sciences Inc.) and more on Quantisnow.

Cantor Fitzgerald Maintains Neutral on Gilead Sciences, Lowers Price Target to $70 | Quantisnow